Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:March 11, 2022Completed
Condition(s):Multiple MyelomaLast Updated:August 29, 2018Unknown status
Condition(s):Multiple MyelomaLast Updated:July 2, 2010Completed
Condition(s):Multiple MyelomaLast Updated:August 15, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:February 10, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:April 6, 2017Completed
Condition(s):Multiple MyelomaLast Updated:September 9, 2020Completed
Condition(s):Multiple MyelomaLast Updated:March 5, 2024Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:June 9, 2023Completed
Condition(s):Multiple MyelomaLast Updated:February 9, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.